Molecular Psychiatry - Table of Contents alert Volume 17 Issue 12

TABLE OF CONTENTS Volume 17, Issue 12 (December 2012) In this issue Image News and Commentary Letters to the Editor Perspectives Reviews Feature Review Expert Reviews Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Translational Psychiatry now indexed by Thomson Reuters Web of Science We are pleased to inform you that Translational Psychiatry has qualified for coverage in Thomson Reuters products and services is now indexed and abstracted in: - Web of Science - MEDLINE - PubMed   Image Top Effects of citalopram on serotonin neurotransmission S Selvaraj, P Faulkner, E Mouchlianitis, J P Roiser and O Howes Mol Psychiatry 2012 17: 1143; 10.1038/mp.2012.166 Full Text News and Commentary Top Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis J G Martins, H Bentsen and B K Puri Mol Psychiatry 2012 17: 1144-1149; advance online publication, April 10, 2012; 10.1038/mp.2012.25 Full Text Letters to the Editor Top Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals G P Amminger, M R Schäfer, C M Klier, J-M Slavik, I Holzer, M Holub, S Goldstone, T J Whitford, P D McGorry and M Berk Mol Psychiatry 2012 17: 1150-1152; advance online publication, December 20, 2011; 10.1038/mp.2011.167 Full Text Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function S Bhattacharyya, Z Atakan, R Martin-Santos, J A Crippa, J Kambeitz, D Prata, S Williams, M Brammer, D A Collier and P K McGuire Mol Psychiatry 2012 17: 1152-1155; advance online publication, January 31, 2012; 10.1038/mp.2011.187 Full Text Schizophrenia risk gene ZNF804A does not influence macroscopic brain structure: an MRI study in 892 volunteers Open H Cousijn, M Rijpkema, A Harteveld, P J Harrison, G Fernández, B Franke and A Arias-Vásquez Mol Psychiatry 2012 17: 1155-1157; advance online publication, January 24, 2012; 10.1038/mp.2011.181 Full Text Oxytocin receptor (OXTR) is not associated with optimism in the Nurses’ Health Study M C Cornelis, M M Glymour, S-C Chang, E J T Tchetgen, L Liang, K C Koenen, J H Kang, L R Pasquale, E B Rimm, I Kawachi and L D Kubzansky Mol Psychiatry 2012 17: 1157-1159; advance online publication, January 3, 2012; 10.1038/mp.2011.178 Full Text Prenatal exposure to maternal obesity leads to hyperactivity in offspring C Fernandes, H Grayton, L Poston, A-M Samuelsson, P D Taylor, D A Collier and A Rodriguez Mol Psychiatry 2012 17: 1159-1160; advance online publication, December 13, 2011; 10.1038/mp.2011.164 Full Text Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression P-Y Lin, D Mischoulon, M P Freeman, Y Matsuoka, J Hibbeln, R H Belmaker and K-P Su Mol Psychiatry 2012 17: 1161-1163; advance online publication, July 24, 2012; 10.1038/mp.2012.111 Full Text Response to critiques on ‘Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis’ M H Bloch and J Hannestad Mol Psychiatry 2012 17: 1163-1167; advance online publication, August 7, 2012; 10.1038/mp.2012.116 Full Text Perspectives Top Another view of the history of antipsychotic drug discovery and development W T Carpenter, Jr and J M Davis Mol Psychiatry 2012 17: 1168-1173; advance online publication, August 14, 2012; 10.1038/mp.2012.121 Abstract | Full Text Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? S Kapur, A G Phillips and T R Insel Mol Psychiatry 2012 17: 1174-1179; advance online publication, August 7, 2012; 10.1038/mp.2012.105 Abstract | Full Text Managing sensitive phenotypic data and biomaterial in large-scale collaborative psychiatric genetic research projects: practical considerations S Y Demiroglu, D Skrowny, M Quade, J Schwanke, M Budde, V Gullatz, D Reich-Erkelenz, J J Jakob, P Falkai, O Rienhoff, K Helbing, U Heilbronner and T G Schulze Mol Psychiatry 2012 17: 1180-1185; advance online publication, March 6, 2012; 10.1038/mp.2012.11 Abstract | Full Text Reviews Top Efficacy and safety of antidepressant drug treatment in children and adolescents A Henry, M D Kisicki and C Varley Mol Psychiatry 2012 17: 1186-1193; advance online publication, November 8, 2011; 10.1038/mp.2011.150 Abstract | Full Text An environmental analysis of genes associated with schizophrenia: hypoxia and vascular factors as interacting elements in the neurodevelopmental model R Schmidt-Kastner, J van Os, G Esquivel, H W M Steinbusch and B P F Rutten Mol Psychiatry 2012 17: 1194-1205; advance online publication, January 31, 2012; 10.1038/mp.2011.183 Abstract | Full Text Feature Review Top Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents S Miyamoto, N Miyake, L F Jarskog, W W Fleischhacker and J A Lieberman Mol Psychiatry 2012 17: 1206-1227; advance online publication, May 15, 2012; 10.1038/mp.2012.47 Abstract | Full Text Expert Reviews Top Neurodevelopmental model of schizophrenia: update 2012 J L Rapoport, J N Giedd and N Gogtay Mol Psychiatry 2012 17: 1228-1238; advance online publication, April 10, 2012; 10.1038/mp.2012.23 Abstract | Full Text Modeling psychiatric disorders at the cellular and network levels K J Brennand, A Simone, N Tran and F H Gage Mol Psychiatry 2012 17: 1239-1253; advance online publication, April 3, 2012; 10.1038/mp.2012.20 Abstract | Full Text Original Articles Top Measuring endogenous changes in serotonergic neurotransmission in humans: a [11C]CUMI-101 PET challenge study S Selvaraj, F Turkheimer, L Rosso, P Faulkner, E Mouchlianitis, J P Roiser, P McGuire, P J Cowen and O Howes Mol Psychiatry 2012 17: 1254-1260; advance online publication, June 5, 2012; 10.1038/mp.2012.78 Abstract | Full Text Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations Open N Farra, W-B Zhang, P Pasceri, J H Eubanks, M W Salter and J Ellis Mol Psychiatry 2012 17: 1261-1271; advance online publication, January 10, 2012; 10.1038/mp.2011.180 Abstract | Full Text Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis M H Bloch and J Hannestad Mol Psychiatry 2012 17: 1272-1282; advance online publication, September 20, 2011; 10.1038/mp.2011.100 Abstract | Full Text CRF2 receptor-deficiency eliminates opiate withdrawal distress without impairing stress coping M Ingallinesi, K Rouibi, C Le Moine, F Papaleo and A Contarino Mol Psychiatry 2012 17: 1283-1294; advance online publication, September 27, 2011; 10.1038/mp.2011.119 Abstract | Full Text Mechanisms of initiation and reversal of drug-seeking behavior induced by prenatal exposure to glucocorticoids A J Rodrigues, P Leão, J M Pêgo, D Cardona, M M Carvalho, M Oliveira, B M Costa, A F Carvalho, P Morgado, D Araújo, J A Palha, O F X Almeida and N Sousa Mol Psychiatry 2012 17: 1295-1305; advance online publication, October 4, 2011; 10.1038/mp.2011.126 Abstract | Full Text Evidence for multiple genetic factors underlying the DSM-IV criteria for alcohol dependence K S Kendler, S H Aggen, C A Prescott, J Crabbe and M C Neale Mol Psychiatry 2012 17: 1306-1315; advance online publication, November 22, 2011; 10.1038/mp.2011.153 Abstract | Full Text Genome-wide association study of Alzheimer's disease with psychotic symptoms P Hollingworth, R Sweet, R Sims, D Harold, G Russo, R Abraham, A Stretton, N Jones, A Gerrish, J Chapman, D Ivanov, V Moskvina, S Lovestone, P Priotsi, M Lupton, C Brayne, M Gill, B Lawlor, A Lynch, D Craig, B McGuinness, J Johnston, C Holmes, G Livingston, N J Bass, H Gurling, A McQuillin, the GERAD Consortium11, the National Institute on Aging Late-Onset Alzheimer's Disease Family Study Group12, P Holmans, L Jones, B Devlin, L Klei, M M Barmada, F Y Demirci, S T DeKosky, O L Lopez, P Passmore, M J Owen, M C O'Donovan, R Mayeux, M I Kamboh and J Williams Mol Psychiatry 2012 17: 1316-1327; advance online publication, October 18, 2011; 10.1038/mp.2011.125 Abstract | Full Text Promoter polymorphisms in two overlapping 6p25 genes implicate mitochondrial proteins in cognitive deficit in schizophrenia A Jablensky, D Angelicheva, G J Donohoe, M Cruickshank, D N Azmanov, D W Morris, A McRae, C S Weickert, K W Carter, D Chandler, B Alexandrov, A Usheva, B Morar, P L Verbrugghe, A Filipovska, O Rackham, A R Bishop, K Ø Rasmussen, M Dragovic, M Cooper, M Phillips, J Badcock, E Bramon-Bosch, O P Almeida, L Flicker, M Gill, A Corvin, S MacGregor and L Kalaydjieva Mol Psychiatry 2012 17: 1328-1339; advance online publication, October 4, 2011; 10.1038/mp.2011.129 Abstract | Full Text Genome-wide association analysis of age-at-onset in Alzheimer's disease M I Kamboh, M M Barmada, F Y Demirci, R L Minster, M M Carrasquillo, V S Pankratz, S G Younkin, A J Saykin, The Alzheimer's Disease Neuroimaging Initiative4, R A Sweet, E Feingold, S T DeKosky and O L Lopez Mol Psychiatry 2012 17: 1340-1346; advance online publication, October 18, 2011; 10.1038/mp.2011.135 Abstract | Full Text De novo induction of amyloid-β deposition in vivo R Morales, C Duran-Aniotz, J Castilla, L D Estrada and C Soto Mol Psychiatry 2012 17: 1347-1353; advance online publication, October 4, 2011; 10.1038/mp.2011.120 Abstract | Full Text Advertisement The #1 journal in psychiatry! Molecular Psychiatry is the place to submit your best work! With Nature Publishing Group benefits like fast and easy online submission, Advanced Online Publication (AOP), wide exposure and so much more, there’s no reason to hesitate. Visit www.nature.com/mp to learn more.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Molecular Psychiatry. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.